Principle Wealth Partners LLC
Source: SEC Form 13F · as of Mar 2026Principle Wealth Partners LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $90.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$90.2M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 113,128 | $27.7M |
| LLYELI LILLY & Co | 12,174 | $11.2M |
| AMGNAMGEN INC | 31,526 | $11.1M |
| MRKMerck & Co., Inc. | 80,052 | $9.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 26,862 | $7.3M |
| ABBVAbbVie Inc. | 33,059 | $7.2M |
| PMPhilip Morris International Inc | 35,016 | $5.8M |
| PFEPFIZER INC | 163,441 | $4.6M |
| ABTABBOTT LABORATORIES | 8,382 | $861K |
| ZTSZoetis Inc. | 6,706 | $793K |
| BMYBRISTOL MYERS SQUIBB CO | 12,485 | $757K |
| ELVElevance Health Inc. | 2,555 | $748K |
| NVSNovartis AG | 4,772 | $729K |
| GMOptec International, Inc. | 8,155 | $608K |
| NVONovo Nordisk A/S | 12,365 | $454K |
| GILDGILEAD SCIENCES, INC. | 2,419 | $337K |
| IQVIQVIA Holdings Inc. | 1,920 | $327K |
| VTRSViatris Inc | 12,242 | $165K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.